If you’re wondering what micro-infusion actually is, we break it down in more detail below. But in short, micro-infusion is a ...
With a median follow-up of 4.2 years, patients receiving blinatumomab achieved a 4-year disease-free survival (DFS) of 83.3% ...
Baptist Hospitals of Southeast Texas has unveiled its new 40,000-square-foot cancer treatment center in Beaumont.
Hallmark did the coolest thing for actress and director Yan-Kay Crystal Lowe as she finished her chemo treatments for breast ...
Vascular Access Device Market OverviewThe global vascular access device market is witnessing consistent growth and is ...
The number of people waiting for the state to provide court-mandated mental health treatment has grown by 58% in the last two ...
South Wales Argus on MSN
Schools 'at breaking point' - urging government to 'save education in Wales'
Schools in Wales are at breaking point, a union leader has said.
Recently, new immune-based treatments have shown impressive results when multiple myeloma returns, changing how doctors treat patients early after relapse.
Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.
Japanese drugmaker Chugai today revealed it has filed a regulatory application with the Ministry of Health, Labor and Welfare (MHLW) for the anti-cancer agent/humanized anti-PD-L1 monoclonal antibody ...
More Today Skincare and Wellness Studio in Astoria has just what your skin has been longing for in an environment that feels ...
DARZALEX FASPRO ® U.S. Prescribing Information. 2 Johnson & Johnson Innovative Medicine. DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results